PRKAG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.120800E-01
Normal-vs-Stage2
5.960400E-01
Normal-vs-Stage3
1.505590E-01
Normal-vs-Stage4
2.528200E-01
Stage1-vs-Stage2
8.736000E-01
Stage1-vs-Stage3
1.366160E-01
Stage1-vs-Stage4
3.076800E-01
Stage2-vs-Stage3
1.965190E-01
Stage2-vs-Stage4
3.281400E-01
Stage3-vs-Stage4
7.681200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.163800E-01
Normal-vs-AfricanAmerican
7.616600E-01
Normal-vs-Asian
2.555800E-01
Caucasian-vs-AfricanAmerican
1.755650E-01
Caucasian-vs-Asian
1.274800E-01
AfricanAmerican-vs-Asian
9.296100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.214200E-01
Normal-vs-Female
6.290600E-01
Male-vs-Female
9.579400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.793200E-01
Normal-vs-Age(41-60Yrs)
9.512800E-01
Normal-vs-Age(61-80Yrs)
4.280200E-01
Normal-vs-Age(81-100Yrs)
5.348000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.194400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.321000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.639600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.935700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.771800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.827200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.590600E-01
Normal-vs-Daily Drinker
3.142200E-01
Normal-vs-Weekly Drinker
7.843200E-01
Normal-vs-Occasional Drinker
8.211400E-01
Normal-vs-Social Drinker
7.011600E-01
Non Drinker-vs-Daily Drinker
9.456200E-01
Non Drinker-vs-Weekly Drinker
5.254800E-01
Non Drinker-vs-Occasional Drinker
2.701000E-01
Non Drinker-vs-Social Drinker
4.369400E-01
Daily Drinker-vs-Weekly Drinker
5.232600E-01
Daily Drinker-vs-Occasional Drinker
1.945570E-01
Daily Drinker-vs-Social Drinker
3.372000E-01
Weekly Drinker-vs-Occasional Drinker
8.122000E-01
Weekly Drinker-vs-Social Drinker
9.825200E-01
Occasional Drinker-vs-Social Drinker
7.871200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.444000E-01
Normal-vs-Grade 2
9.394400E-01
Normal-vs-Grade 3
9.087600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.387200E-01
Grade 1-vs-Grade 3
5.909600E-01
Grade 1-vs-Grade 4
9.444000E-01
Grade 2-vs-Grade 3
3.960200E-01
Grade 2-vs-Grade 4
9.394400E-01
Grade 3-vs-Grade 4
9.087600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.727000E-01
Normal-vs-NonDiabetic
6.721200E-01
Diabetic-vs-NonDiabetic
3.462000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.828800E-01
Normal-vs-NoPancreatitis
6.215000E-01
Pancreatitis-vs-NoPancreatitis
9.459000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.284200E-01
Normal-vs-N1
6.054200E-01
N0-vs-N1
9.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.148000E-01
Normal-vs-TP53-NonMutant
7.179600E-01
TP53-Mutant-vs-TP53-NonMutant
4.461200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
